Effects of atherosclerosis on the coronary microcirculation

W. M. Chilian, Kevin C Dellsperger, S. M. Layne, C. L. Eastham, M. A. Armstrong, M. L. Marcus, D. D. Heistad

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

We tested the hypothesis that atherosclerosis potentiates coronary vasoconstriction to serotonin and ergonovine. Coronary microvascular pressures and diameters were measured in the beating left ventricle in normal and atherosclerotic cynomolgus monkeys. Pressures were measured in arteries (190-350 μm diam) that were distal to atherosclerotic lesions. Microvascular pressure and simultaneous measurements of aortic pressure and myocardial blood flow were used to calculate segmental vascular resistance (large artery resistance and microvascular resistance) during serotonin, phenylephrine, and ergonovine dosages. Aortic pressure was maintained constant during all interventions. Administration of phenylephrine (50 μg·kg-1·min-1 iv) produced a similar increase in microvascular resistance from base line (P < 0.05) in atherosclerotic and normal animals, 26 ± 5 and 14 ± 9 mmHg·min·g·ml-1, respectively. Serotonin (50 μg/min) did not influence coronary resistance in normal animals but produced a significant increase in both large artery (8 ± 3 mmHg·min·g·ml-1) and microvascular resistance (21 ± 6 mmHg·min·g·ml-1) in atherosclerotic animals (P < 0.05). A higher dose of serotonin (200 μg/min) produced a modest increase in large artery resistance from base line in normal animals (3 ± 1 mmHg·min·g·ml-1) and a greater increase in atherosclerotic animals (9 ± 4 mmHg·min·g·ml-1) (P < 0.05) vs. normals). Ergonovine (10 μg·kg-1·min-1 iv elevated microvascular resistance in both normal and atherosclerotic animals (P < 0.05) but increased large artery resistance only in atherosclerotic animals (10 ± 4 mmHg·min·g·ml-1) (P < 0.05). In summary, coronary vasoconstrictor responses to serotonin and ergonovine were potentiated by atherosclerosis. Because augmented constrictor responses to serotonin were observed in both the diseased arteries and the microcirculation of atherosclerotic animals, we speculate that the pathophysiological consequences of atherosclerosis extend into the microcirculation.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume258
Issue number2 27-2
StatePublished - Jan 1 1990

Fingerprint

Microcirculation
Coronary Artery Disease
Ergonovine
Serotonin
Arteries
Phenylephrine
Pressure
Atherosclerosis
Arterial Pressure
Macaca fascicularis
Vasoconstrictor Agents
Vasoconstriction
Vascular Resistance
Heart Ventricles

Keywords

  • coronary resistance
  • phenylephrine
  • serotonin
  • α-adrenoceptors

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Chilian, W. M., Dellsperger, K. C., Layne, S. M., Eastham, C. L., Armstrong, M. A., Marcus, M. L., & Heistad, D. D. (1990). Effects of atherosclerosis on the coronary microcirculation. American Journal of Physiology - Heart and Circulatory Physiology, 258(2 27-2).

Effects of atherosclerosis on the coronary microcirculation. / Chilian, W. M.; Dellsperger, Kevin C; Layne, S. M.; Eastham, C. L.; Armstrong, M. A.; Marcus, M. L.; Heistad, D. D.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 258, No. 2 27-2, 01.01.1990.

Research output: Contribution to journalArticle

Chilian, WM, Dellsperger, KC, Layne, SM, Eastham, CL, Armstrong, MA, Marcus, ML & Heistad, DD 1990, 'Effects of atherosclerosis on the coronary microcirculation', American Journal of Physiology - Heart and Circulatory Physiology, vol. 258, no. 2 27-2.
Chilian WM, Dellsperger KC, Layne SM, Eastham CL, Armstrong MA, Marcus ML et al. Effects of atherosclerosis on the coronary microcirculation. American Journal of Physiology - Heart and Circulatory Physiology. 1990 Jan 1;258(2 27-2).
Chilian, W. M. ; Dellsperger, Kevin C ; Layne, S. M. ; Eastham, C. L. ; Armstrong, M. A. ; Marcus, M. L. ; Heistad, D. D. / Effects of atherosclerosis on the coronary microcirculation. In: American Journal of Physiology - Heart and Circulatory Physiology. 1990 ; Vol. 258, No. 2 27-2.
@article{7ad56a3bf22346bd901d5efcc8f0632f,
title = "Effects of atherosclerosis on the coronary microcirculation",
abstract = "We tested the hypothesis that atherosclerosis potentiates coronary vasoconstriction to serotonin and ergonovine. Coronary microvascular pressures and diameters were measured in the beating left ventricle in normal and atherosclerotic cynomolgus monkeys. Pressures were measured in arteries (190-350 μm diam) that were distal to atherosclerotic lesions. Microvascular pressure and simultaneous measurements of aortic pressure and myocardial blood flow were used to calculate segmental vascular resistance (large artery resistance and microvascular resistance) during serotonin, phenylephrine, and ergonovine dosages. Aortic pressure was maintained constant during all interventions. Administration of phenylephrine (50 μg·kg-1·min-1 iv) produced a similar increase in microvascular resistance from base line (P < 0.05) in atherosclerotic and normal animals, 26 ± 5 and 14 ± 9 mmHg·min·g·ml-1, respectively. Serotonin (50 μg/min) did not influence coronary resistance in normal animals but produced a significant increase in both large artery (8 ± 3 mmHg·min·g·ml-1) and microvascular resistance (21 ± 6 mmHg·min·g·ml-1) in atherosclerotic animals (P < 0.05). A higher dose of serotonin (200 μg/min) produced a modest increase in large artery resistance from base line in normal animals (3 ± 1 mmHg·min·g·ml-1) and a greater increase in atherosclerotic animals (9 ± 4 mmHg·min·g·ml-1) (P < 0.05) vs. normals). Ergonovine (10 μg·kg-1·min-1 iv elevated microvascular resistance in both normal and atherosclerotic animals (P < 0.05) but increased large artery resistance only in atherosclerotic animals (10 ± 4 mmHg·min·g·ml-1) (P < 0.05). In summary, coronary vasoconstrictor responses to serotonin and ergonovine were potentiated by atherosclerosis. Because augmented constrictor responses to serotonin were observed in both the diseased arteries and the microcirculation of atherosclerotic animals, we speculate that the pathophysiological consequences of atherosclerosis extend into the microcirculation.",
keywords = "coronary resistance, phenylephrine, serotonin, α-adrenoceptors",
author = "Chilian, {W. M.} and Dellsperger, {Kevin C} and Layne, {S. M.} and Eastham, {C. L.} and Armstrong, {M. A.} and Marcus, {M. L.} and Heistad, {D. D.}",
year = "1990",
month = "1",
day = "1",
language = "English (US)",
volume = "258",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "2 27-2",

}

TY - JOUR

T1 - Effects of atherosclerosis on the coronary microcirculation

AU - Chilian, W. M.

AU - Dellsperger, Kevin C

AU - Layne, S. M.

AU - Eastham, C. L.

AU - Armstrong, M. A.

AU - Marcus, M. L.

AU - Heistad, D. D.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - We tested the hypothesis that atherosclerosis potentiates coronary vasoconstriction to serotonin and ergonovine. Coronary microvascular pressures and diameters were measured in the beating left ventricle in normal and atherosclerotic cynomolgus monkeys. Pressures were measured in arteries (190-350 μm diam) that were distal to atherosclerotic lesions. Microvascular pressure and simultaneous measurements of aortic pressure and myocardial blood flow were used to calculate segmental vascular resistance (large artery resistance and microvascular resistance) during serotonin, phenylephrine, and ergonovine dosages. Aortic pressure was maintained constant during all interventions. Administration of phenylephrine (50 μg·kg-1·min-1 iv) produced a similar increase in microvascular resistance from base line (P < 0.05) in atherosclerotic and normal animals, 26 ± 5 and 14 ± 9 mmHg·min·g·ml-1, respectively. Serotonin (50 μg/min) did not influence coronary resistance in normal animals but produced a significant increase in both large artery (8 ± 3 mmHg·min·g·ml-1) and microvascular resistance (21 ± 6 mmHg·min·g·ml-1) in atherosclerotic animals (P < 0.05). A higher dose of serotonin (200 μg/min) produced a modest increase in large artery resistance from base line in normal animals (3 ± 1 mmHg·min·g·ml-1) and a greater increase in atherosclerotic animals (9 ± 4 mmHg·min·g·ml-1) (P < 0.05) vs. normals). Ergonovine (10 μg·kg-1·min-1 iv elevated microvascular resistance in both normal and atherosclerotic animals (P < 0.05) but increased large artery resistance only in atherosclerotic animals (10 ± 4 mmHg·min·g·ml-1) (P < 0.05). In summary, coronary vasoconstrictor responses to serotonin and ergonovine were potentiated by atherosclerosis. Because augmented constrictor responses to serotonin were observed in both the diseased arteries and the microcirculation of atherosclerotic animals, we speculate that the pathophysiological consequences of atherosclerosis extend into the microcirculation.

AB - We tested the hypothesis that atherosclerosis potentiates coronary vasoconstriction to serotonin and ergonovine. Coronary microvascular pressures and diameters were measured in the beating left ventricle in normal and atherosclerotic cynomolgus monkeys. Pressures were measured in arteries (190-350 μm diam) that were distal to atherosclerotic lesions. Microvascular pressure and simultaneous measurements of aortic pressure and myocardial blood flow were used to calculate segmental vascular resistance (large artery resistance and microvascular resistance) during serotonin, phenylephrine, and ergonovine dosages. Aortic pressure was maintained constant during all interventions. Administration of phenylephrine (50 μg·kg-1·min-1 iv) produced a similar increase in microvascular resistance from base line (P < 0.05) in atherosclerotic and normal animals, 26 ± 5 and 14 ± 9 mmHg·min·g·ml-1, respectively. Serotonin (50 μg/min) did not influence coronary resistance in normal animals but produced a significant increase in both large artery (8 ± 3 mmHg·min·g·ml-1) and microvascular resistance (21 ± 6 mmHg·min·g·ml-1) in atherosclerotic animals (P < 0.05). A higher dose of serotonin (200 μg/min) produced a modest increase in large artery resistance from base line in normal animals (3 ± 1 mmHg·min·g·ml-1) and a greater increase in atherosclerotic animals (9 ± 4 mmHg·min·g·ml-1) (P < 0.05) vs. normals). Ergonovine (10 μg·kg-1·min-1 iv elevated microvascular resistance in both normal and atherosclerotic animals (P < 0.05) but increased large artery resistance only in atherosclerotic animals (10 ± 4 mmHg·min·g·ml-1) (P < 0.05). In summary, coronary vasoconstrictor responses to serotonin and ergonovine were potentiated by atherosclerosis. Because augmented constrictor responses to serotonin were observed in both the diseased arteries and the microcirculation of atherosclerotic animals, we speculate that the pathophysiological consequences of atherosclerosis extend into the microcirculation.

KW - coronary resistance

KW - phenylephrine

KW - serotonin

KW - α-adrenoceptors

UR - http://www.scopus.com/inward/record.url?scp=0025326064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025326064&partnerID=8YFLogxK

M3 - Article

C2 - 2309917

AN - SCOPUS:0025326064

VL - 258

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 2 27-2

ER -